Pharmacological activation of the S1P receptor by fingolimod increased the levels of brain derived neurotrophic factor (BDNF) and increased the size of the striatum in treated Mecp2 knockout mice as a model of Rett syndrome. Here, BDNF is linked to atypical Rett syndrome.